PT-141 for Laboratory Research

PT-141 is a synthetic cyclic heptapeptide: it comprises seven amino-acid residues and has a ring-containing architecture. The condensed reference sequence is Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH. In this notation, Nle denotes norleucine, D-Phe denotes D-phenylalanine and Ac denotes N-terminal acetylation. The paired “(1)” marks show side-chain closure between Asp and Lys. This information describes the reference structure, not the identity of material in an individual batch.

PubChem records the free peptide form under CID 9941379. Database identifiers assist reconciliation, but a name or database record cannot establish the physical form, counter-ion, content or analytical result of supplied material. Those points require the product specification and matching batch documentation. CAS identifier, molecular formula and molecular mass below describe the free peptide as a reference identity; the salt or solvate form and the measured content of any supplied batch remain a question for that batch’s COA.

Reference identity and batch identity are separate questions. Sequence notation can describe structural features, while analytical records document what was tested, by which method and for which batch. Neither should be substituted for the other.

Reference-identity source: PubChem CID 9941379 · Bioanalytical source: Sauter et al. 2020 · PMID 32353679

PT-141 is classified in the literature as a melanocortin-receptor agonist. “Agonist” means that receptor activation was observed within an appropriate experimental system; it is not a complete account of biological action. The reported target profile includes MC1R, MC3R and MC4R. These receptors belong to the G-protein-coupled receptor family, but a receptor name alone does not define assay conditions, signalling readout or comparative selectivity.

Comparisons across publications therefore require attention to receptor construct, model, exposure conditions, timing and endpoint. A signal measured in an engineered cell system cannot be treated as equivalent to a behavioural measure in an animal model or a physiological variable in a controlled human study. Apparent agreement at the receptor-label level does not erase these differences.

Reviews can place cyclic analogues within the historical development of melanocortin research and organise earlier findings. Their value is classificatory and interpretive: a review does not create a new primary measurement, establish the performance of an untested material or authenticate a supplied batch. The distinction between reference pharmacology and batch documentation remains essential throughout this evidence map.

Pharmacology source: Hadley and Dorr 2006 · PMID 16412534

This section describes findings in controlled research and makes no statement about use. The six records cover a validated bioanalytical method with an animal pharmacokinetic application, a behavioural animal model, two randomised human designs and two reviews. They answer different questions and must not be merged into a single expected result. The sequence below moves from laboratory measurement through animal and human research to secondary synthesis.

The two human records use different measurement frameworks and cannot be treated as replications of one endpoint. The rodent record remains preclinical. The analytical record validates a measurement approach in its stated matrix and method, not the composition of unrelated material. Reviews organise primary studies but sit at a different evidence level.

“PT-141” is the research code used throughout this record. “Synthetic” distinguishes laboratory production from an endogenous peptide, “heptapeptide” states that seven amino-acid residues are present, and “cyclic” describes the side-chain ring closure. “Melanocortin-receptor agonist” is a pharmacological classification. None of these terms, separately or together, authenticates the content of a container or provides a method-specific analytical result.

Likewise, receptor target, model and endpoint are not interchangeable terms. MC1R, MC3R and MC4R name receptor subtypes. In vitro refers to a controlled laboratory system outside an intact organism. An animal model addresses species-bound experimental questions. A randomised crossover design controls sequence and comparison within its defined participant framework. A review evaluates existing literature without adding a fresh primary measurement.

“Pharmacokinetic” describes measurements of concentration over time within a specified study design. “Bioanalytical” describes the validated measurement process used for a defined matrix. Neither term certifies an unrelated batch. Study findings must remain attached to author, year, journal, model and endpoint class.

These distinctions prevent evidence inflation. A mechanistic classification cannot be converted into a whole-organism prediction, a rodent observation cannot be transferred to humans, a participant measurement cannot become a characteristic of research material, and a review cannot replace primary data or batch analysis.

Classification review: Edinoff et al. 2022 · PMID 35076581

PT-141 is supplied as laboratory research material. The applicable product specification and matching batch documentation should connect the substance designation, batch code, test date, analytical method and reported result. Any discrepancy between these records should be resolved before material is assigned to a controlled experiment. No fill quantity, physical form, storage condition or stability period is asserted in this field set.

HPLC can document a chromatographic profile and a method-specific numerical result for the tested batch. Such a result applies only to that batch and the stated method; it is not a blanket purity claim. Chromatographic evidence and molecular-identity evidence also answer different analytical questions. The Certificate of Analysis should be read with the released product specification, without extending either document beyond what it reports.

Published receptor, animal, human and review literature provides context for experimental questions but does not certify supplied material. Laboratory records should preserve the separation between reference identity, study evidence, product specification and batch-specific analysis. This documentation-led boundary is central to responsible research-only handling.

Research use only. For laboratory research only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Not a medicinal product, food or cosmetic.